Ayman Maher Nagib Selected Research

Ayman Maher Nagib Research Topics

2	Hypercholesterolemia 01/2024 - 08/2015
2	Body Weight (Weight, Body) 01/2022 - 08/2015
1	Hyperkalemia 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Diabetes Mellitus 01/2019
1	Hepatitis B 10/2015
1	Proteinuria 08/2015
1	Insulin Resistance 08/2015
1	Delayed Graft Function 03/2014

1	SubtilisinIBA 01/2024
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024
1	Essential DrugsIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Sulfamethoxazole FDA LinkGeneric 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2022
1	FludrocortisoneIBA 01/2022
1	PotassiumIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 08/2015
1	ApelinIBA 08/2015

2	Therapeutics 01/2024 - 03/2014
1	Glycemic Control 01/2019